Literature DB >> 10991957

Inhibition of volume-regulated and calcium-activated chloride channels by the antimalarial mefloquine.

C Maertens1, L Wei, G Droogmans, B Nilius.   

Abstract

We have used the whole-cell patch-clamp technique to study the effect of mefloquine (Lariam), a commonly used antimalarial drug, on the volume-regulated anion channel (VRAC) in cultured bovine pulmonary artery endothelial cells. We also examined its effects on other Cl(-) channels, i.e., the Ca(2+)-activated Cl(-) channel and the cystic fibrosis transmembrane conductance regulator, to assess the specificity of this compound for VRAC. At pH 7.4 mefloquine induced a fast and reversible block of the volume-sensitive chloride current (I(Cl,swell)), with an IC(50) value of 1.19 +/- 0.07 microM. The blocking efficiency increased with increasing extracellular pH (IC(50) value for pH 8.8 was 0.15 +/- 0.01 microM), indicating that this effect is mediated by the uncharged form of mefloquine. Ca(2+)-activated Cl(-) currents, I(Cl,Ca), activated by loading T84 cells via the patch pipette with 1 microM free Ca(2+) also were inhibited by mefloquine (IC(50) value 3.01 +/- 0.17 microM at pH 7.4). The cystic fibrosis transmembrane conductance regulator channel, transiently transfected in cultured bovine pulmonary artery endothelial cells, was not affected by 10 microM of the drug. This study describes for the first time effects of mefloquine on anion channels. Our data reveal a potent block of VRAC and Ca(2+)-activated Cl(-) channel at therapeutic concentrations. These results may contribute to a better understanding of the actions and side effects of this widely used antimalarial drug.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991957

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Utility of alkylaminoquinolinyl methanols as new antimalarial drugs.

Authors:  G S Dow; T N Heady; A K Bhattacharjee; D Caridha; L Gerena; M Gettayacamin; C A Lanteri; N Obaldia; N Roncal; T Shearer; P L Smith; A Tungtaeng; L Wolf; M Cabezas; D Yourick; K S Smith
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

2.  Reversal of loss of bone mass in old mice treated with mefloquine.

Authors:  Rafael Pacheco-Costa; Hannah M Davis; Emily G Atkinson; Julian E Dilley; Innocent Byiringiro; Mohammad W Aref; Matthew R Allen; Teresita Bellido; Lilian I Plotkin
Journal:  Bone       Date:  2018-06-05       Impact factor: 4.398

3.  Potent block of Cx36 and Cx50 gap junction channels by mefloquine.

Authors:  Scott J Cruikshank; Matthew Hopperstad; Meg Younger; Barry W Connors; David C Spray; Miduturu Srinivas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

Review 4.  Diversity of Cl(-) channels.

Authors:  M Suzuki; T Morita; T Iwamoto
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

5.  Spontaneous rhythmogenic capabilities of sympathetic neuronal assemblies in the rat spinal cord slice.

Authors:  M L Pierce; J Deuchars; S A Deuchars
Journal:  Neuroscience       Date:  2010-07-25       Impact factor: 3.590

6.  Anti-malaria drug mefloquine induces motor learning deficits in humans.

Authors:  Thomas A van Essen; Ruben S van der Giessen; Sebastiaan K E Koekkoek; Frans Vanderwerf; Chris I De Zeeuw; Perry J J van Genderen; David Overbosch; Marcel T G de Jeu
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

7.  Distinct pharmacological and molecular properties of the acid-sensitive outwardly rectifying (ASOR) anion channel from those of the volume-sensitive outwardly rectifying (VSOR) anion channel.

Authors:  Kaori Sato-Numata; Tomohiro Numata; Ryuji Inoue; Yasunobu Okada
Journal:  Pflugers Arch       Date:  2016-01-08       Impact factor: 3.657

Review 8.  Biophysics and Physiology of the Volume-Regulated Anion Channel (VRAC)/Volume-Sensitive Outwardly Rectifying Anion Channel (VSOR).

Authors:  Stine F Pedersen; Yasunobu Okada; Bernd Nilius
Journal:  Pflugers Arch       Date:  2016-01-06       Impact factor: 3.657

Review 9.  Connexin channel modulators and their mechanisms of action.

Authors:  Vytas K Verselis; Miduturu Srinivas
Journal:  Neuropharmacology       Date:  2013-04-15       Impact factor: 5.250

10.  Mefloquine induces dose-related neurological effects in a rat model.

Authors:  G Dow; R Bauman; D Caridha; M Cabezas; F Du; R Gomez-Lobo; M Park; K Smith; K Cannard
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.